Reference of 13196-11-7, Because a catalyst decreases the height of the energy barrier, its presence increases the reaction rates of both the forward and the reverse reactions by the same amount.13196-11-7, Name is Benzofuran-6-ol, molecular formula is C8H6O2. In a article，once mentioned of 13196-11-7
The lead identification of a novel potent selective PPARgamma agonist, DS-6930 is reported. To avoid PPARgamma-related adverse effects, a partial agonist was designed to prevent the direct interaction with helix 12 of PPARgamma-LBD. Because the TZD group is known to interact with helix 12, the TZD in efatutazone (CS-7017) was replaced to discover novel PPARgamma intermediate partial agonist 8i. The optimization of 8i yielded 13ac with high potency in vitro. Compound 13ac exhibited robust plasma glucose lowering effects comparable to those of rosiglitazone (3 mg/kg) in Zucker diabetic fatty rats. Upon toxicological evaluation, compound 13ac (300 mg/kg) induced hemodilution to a lower extent than rosiglitazone; however, 13ac elevated liver enzyme activities. X-ray crystallography revealed no direct interaction of 13ac with helix 12, and the additional lipophilic interactions are also suggested to be related to the maximum transcriptional activity of 13ac.
A reaction mechanism is the microscopic path by which reactants are transformed into products. Each step is an elementary reaction. In my other articles, you can also check out more blogs about 13196-11-7
Reference：
Benzofuran – Wikipedia,
Benzofuran | C8H422O – PubChem